• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTEGRA NEUROSCIENCES PR BIOPATCH, UNKNOWN SIZE/PRODUCT ID; ANTIMICROBIAL PRODUCTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTEGRA NEUROSCIENCES PR BIOPATCH, UNKNOWN SIZE/PRODUCT ID; ANTIMICROBIAL PRODUCTS Back to Search Results
Catalog Number XXX-BIOPATCH
Device Problems Product Quality Problem (1506); Device Operates Differently Than Expected (2913)
Patient Problem Unspecified Infection (1930)
Event Type  Injury  
Manufacturer Narrative
The device involved in the reported incident is not available for evaluation.An investigation has been initiated based on the reported information.
 
Event Description
Asaio journal (2016) published, "retrospective observational review of percutaneous cannulation for extracorporeal membrane oxygenation".The purpose of this article is to describe the approach to cannulation and its complications for patients with severe respiratory failure.It were identified 348 cannulae placed in 179 patients commenced on venovenous extracorporeal membrane oxygenation from december 2011 to march 2015.All cannulas were secured using multiple 1-0 silk ties (minimum 3points) and dressed with chlorhexidine sponge discs (biopatch; ethicon) and occlusive dressings.Cannula site infections occurred in 1.4% (5/348), all of which were managed successfully with intravenous antibiotics.The site infections were not associated with signs of systemic sepsis.There were no bloodstream infections secondary to cannula infection on cultures drawn from circuits where cannula infections were clinically apparent.
 
Manufacturer Narrative
Integra has completed their internal investigation on january 19, 2018.Results: the units involved in the reported incidents were used during a medical study performed from 2011 to 2015 years and are not available to perform a failure analysis.Therefore, the reported condition of infection and/or dermatitis is unconfirmed.Dhr review; no device history record (dhr) was possible since no lot number was identified by the customer.Complaints history; the complaint information indicates that patients suffered ¿cannula site infection¿ during the study.Upon review of integra's complaint system from december 2015 ¿ january 16, 2018, a total of nine (9) complaints (including this one) related to infection for biopatch product family.(b)(4).Conclusion: potential root cause for ¿cannula site infection¿ cannot be determined, because it is unknown the environmental conditions where the patients were exposed during the study and, moreover, the patients¿ conditions prior to the biopatch application.Part of the recommendations for the use of the product is that the ¿biopatch should not be placed over infected wounds.¿ in addition, biopatch¿s ifu literature recognizes the possibility of adverse reactions: ¿adverse reactions to chlorhexidine gluconate such as dermatitis, hypersensitivity, and generalized allergic reactions are very rare, but if any such reactions occur, discontinue use of the dressing immediately.¿.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOPATCH, UNKNOWN SIZE/PRODUCT ID
Type of Device
ANTIMICROBIAL PRODUCTS
Manufacturer (Section D)
INTEGRA NEUROSCIENCES PR
road 402 north, km 1.2
road 402 north, km 1.2
anasco PR 00610
Manufacturer (Section G)
INTEGRA NEUROSCIENCES PR
road 402 north, km 1.2
anasco PR 00610
Manufacturer Contact
sonia irizarry
311 enterprise drive
plainsboro, NJ 08536
6099362393
MDR Report Key7142524
MDR Text Key95723734
Report Number2648988-2017-00059
Device Sequence Number1
Product Code FRO
Combination Product (y/n)N
PMA/PMN Number
K003229
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/28/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/22/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberXXX-BIOPATCH
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received01/19/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Other;
-
-